BCR and B-cell chronic lymphocytic leukemia: In a translational study, we recently demonstrated that mitochondrial respiration is a biomarker for CLL and active B-cell receptor (BCR) signaling in a cohort of 81 CLL patients and decreased with ibrutinib treatment in a small cohort of treated patients [9].